US 9217148
Exon skipping compositions for treating muscular dystrophy
granted A61KA61K31/713A61K47/60
Quick answer
US patent 9217148 (Exon skipping compositions for treating muscular dystrophy) held by Sarepta Therapeutics, Inc. expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Sarepta Therapeutics, Inc.
- Grant date
- Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K31/713, A61K47/60, A61K47/6455, A61P